Free Trial

Best Stocks Under $10 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $10.00 (10 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Birchcliff Energy stock logo

1. Birchcliff Energy OTCMKTS:BIREF

$4.05 -0.17 (-4.03%)
As of 03:43 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.10 billion
P/E Ratio
28.93
Consensus Rating
Strong Buy
Volume
47,109 shares
Average Volume
104,026 shares
Today's Range
$4.02
$4.27
Glencore stock logo

2. Glencore OTCMKTS:GLNCY

$6.48 -0.57 (-8.09%)
As of 03:59 PM Eastern

Glencore plc engages in the production, refinement, processing, storage, transport, and marketing of metals and minerals, and energy products in the Americas, Europe, Asia, Africa, and Oceania. More about Glencore

Market Capitalization
$42.51 billion
Consensus Rating
Strong Buy
Volume
1.21 million shares
Average Volume
1.20 million shares
Today's Range
$6.31
$6.53
50-Day Range
$5.84
$8.35
Serve Robotics stock logo

3. Serve Robotics NASDAQ:SERV

$6.17 -0.28 (-4.34%)
As of 04:00 PM Eastern

Serve Robotics Inc designs, develops, and operates low-emission robots that serve people in public spaces with food delivery in the United States. More about Serve Robotics

Market Capitalization
$351.18 million
P/E Ratio
-5.14
Consensus Rating
Strong Buy
Consensus Price Target
$19.50 (+216.0% Upside)
Volume
2.76 million shares
Average Volume
9.33 million shares
Green Thumb Industries stock logo

4. Green Thumb Industries OTCMKTS:GTBIF

$6.60 +0.71 (+12.05%)
As of 03:59 PM Eastern

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. More about Green Thumb Industries

Market Capitalization
$1.40 billion
P/E Ratio
27.50
Consensus Rating
Strong Buy
Consensus Price Target
$16.50 (+150.0% Upside)
Volume
979,261 shares
Average Volume
483,780 shares
Lundin Mining stock logo

5. Lundin Mining OTCMKTS:LUNMF

$8.15 -0.33 (-3.83%)
As of 03:59 PM Eastern

Lundin Mining Corporation, a diversified base metals mining company, engages in the exploration, development, and mining of mineral properties in Chile, Brazil, the United States, Portugal, Sweden, and Argentina. More about Lundin Mining

Market Capitalization
$7.01 billion
P/E Ratio
22.64
Consensus Rating
Strong Buy
Volume
166,847 shares
Average Volume
303,243 shares
Today's Range
$8.07
$8.65
NexGen Energy stock logo

6. NexGen Energy NYSE:NXE

$5.24 -0.03 (-0.57%)
As of 03:59 PM Eastern

NexGen Energy Ltd., an exploration and development stage company, engages in the acquisition, exploration, and evaluation and development of uranium properties in Canada. More about NexGen Energy

Market Capitalization
$2.98 billion
P/E Ratio
34.94
Consensus Rating
Strong Buy
Volume
7.97 million shares
Average Volume
6.96 million shares
Today's Range
$5.06
$5.27
Stardust Power stock logo

7. Stardust Power NASDAQ:SDST

$0.50 +0.00 (+0.93%)
As of 04:00 PM Eastern

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$28.94 million
Consensus Rating
Buy
Consensus Price Target
$5.11 (+922.7% Upside)
Volume
225,128 shares
Average Volume
347,825 shares
Today's Range
$0.49
$0.51
Maze Therapeutics stock logo

8. Maze Therapeutics NASDAQ:MAZE

$9.25 +0.46 (+5.23%)
As of 04:00 PM Eastern

We are a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. More about Maze Therapeutics

Market Capitalization
$405.11 million
Consensus Rating
Buy
Consensus Price Target
$25.67 (+177.5% Upside)
Volume
799,429 shares
Average Volume
289,143 shares
Today's Range
$8.56
$9.32
Hudbay Minerals stock logo

9. Hudbay Minerals NYSE:HBM

$7.27 -0.17 (-2.28%)
As of 03:59 PM Eastern

Hudbay Minerals Inc, a diversified mining company, focuses on the exploration, development, operation, and optimization of properties in North and South America. More about Hudbay Minerals

Market Capitalization
$2.87 billion
P/E Ratio
40.39
Consensus Rating
Buy
Consensus Price Target
$14.00 (+92.6% Upside)
Volume
4.42 million shares
Average Volume
4.75 million shares
OS Therapies stock logo

10. OS Therapies NYSE:OSTX

$2.03 +0.03 (+1.50%)
As of 04:00 PM Eastern

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$43.98 million
Consensus Rating
Buy
Consensus Price Target
$18.00 (+786.7% Upside)
Volume
328,592 shares
Average Volume
483,587 shares
Today's Range
$1.80
$2.10
zSpace stock logo

11. zSpace NASDAQ:ZSPC

$8.36 -0.39 (-4.46%)
As of 04:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$191.02 million
Consensus Rating
Buy
Consensus Price Target
$15.25 (+82.4% Upside)
Volume
32,041 shares
Average Volume
75,520 shares
Today's Range
$8.04
$9.18
Astria Therapeutics stock logo

12. Astria Therapeutics NASDAQ:ATXS

$5.16 +0.04 (+0.78%)
As of 04:00 PM Eastern

Astria Therapeutics, Inc, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. More about Astria Therapeutics

Market Capitalization
$291.20 million
P/E Ratio
-2.47
Consensus Rating
Buy
Consensus Price Target
$30.00 (+481.4% Upside)
Volume
361,269 shares
Average Volume
372,747 shares
Coeur Mining stock logo

13. Coeur Mining NYSE:CDE

$5.53 0.00 (0.00%)
As of 03:59 PM Eastern

Coeur Mining, Inc explores for precious metals in the United States, Canada, and Mexico. The company primarily explores for gold, silver, zinc, and lead properties. More about Coeur Mining

Market Capitalization
$3.53 billion
P/E Ratio
46.09
Consensus Rating
Buy
Consensus Price Target
$8.10 (+46.5% Upside)
Volume
16.01 million shares
Average Volume
11.66 million shares
Denison Mines stock logo

14. Denison Mines NYSEAMERICAN:DNN

$1.41 -0.01 (-0.70%)
As of 04:10 PM Eastern

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mines

Market Capitalization
$1.26 billion
P/E Ratio
-141.00
Consensus Rating
Buy
Consensus Price Target
$3.00 (+112.8% Upside)
Volume
57.10 million shares
Average Volume
30.28 million shares
Solid Biosciences stock logo

15. Solid Biosciences NASDAQ:SLDB

$3.31 +0.26 (+8.52%)
As of 04:00 PM Eastern

Solid Biosciences Inc, a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. More about Solid Biosciences

Market Capitalization
$256.50 million
P/E Ratio
-1.09
Consensus Rating
Buy
Consensus Price Target
$15.67 (+373.3% Upside)
Volume
985,520 shares
Average Volume
941,264 shares
VNET Group stock logo

16. VNET Group NASDAQ:VNET

$6.29 +0.63 (+11.13%)
As of 04:00 PM Eastern

VNET Group, Inc, an investment holding company, provides hosting and related services in China. It offers managed hosting services consisting of managed retail services, such as colocation services that dedicate data center space to house customers' servers and networking equipment, as well as allow customers to lease partial or entire cabinets for their servers; interconnectivity services that allow customers to connect their servers; value-added services, including hybrid IT, bare metal, firewall, server load balancing, data backup and recovery, data center management, server management, and backup server services; cloud services that allow customers to run applications over the internet using IT infrastructure; and VPN Services that extend customers' private networks by setting up connections through the public internet. More about VNET Group

Market Capitalization
$1.62 billion
P/E Ratio
-2.83
Consensus Rating
Buy
Consensus Price Target
$9.30 (+47.9% Upside)
Volume
8.33 million shares
Average Volume
4.15 million shares
Uranium Energy stock logo

17. Uranium Energy NYSEAMERICAN:UEC

$5.25 -0.06 (-1.13%)
As of 04:10 PM Eastern

Uranium Energy Corp., together with its subsidiaries, engages in exploration, pre-extraction, extraction, and processing uranium and titanium concentrates in the United States, Canada, and Paraguay. More about Uranium Energy

Market Capitalization
$2.22 billion
P/E Ratio
-43.75
Consensus Rating
Buy
Consensus Price Target
$10.60 (+101.9% Upside)
Volume
5.52 million shares
Average Volume
7.76 million shares
Bioceres Crop Solutions stock logo

18. Bioceres Crop Solutions NASDAQ:BIOX

$4.25 -0.02 (-0.47%)
As of 04:00 PM Eastern

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. More about Bioceres Crop Solutions

Market Capitalization
$266.52 million
P/E Ratio
212.61
Consensus Rating
Buy
Consensus Price Target
$8.63 (+102.9% Upside)
Volume
55,864 shares
Average Volume
168,341 shares
OnKure Therapeutics stock logo

19. OnKure Therapeutics NASDAQ:OKUR

$2.49 -0.04 (-1.58%)
As of 04:00 PM Eastern

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$33.46 million
P/E Ratio
-0.20
Consensus Rating
Buy
Consensus Price Target
$32.33 (+1,198.5% Upside)
Volume
53,836 shares
Average Volume
82,057 shares
Trevi Therapeutics stock logo

20. Trevi Therapeutics NASDAQ:TRVI

$6.91 +0.60 (+9.51%)
As of 04:00 PM Eastern

Trevi Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC) conditions targeting the central and peripheral nervous systems. More about Trevi Therapeutics

Market Capitalization
$668.07 million
P/E Ratio
-15.70
Consensus Rating
Buy
Consensus Price Target
$17.56 (+154.2% Upside)
Volume
1.58 million shares
Average Volume
1.14 million shares
GeoVax Labs stock logo

21. GeoVax Labs NASDAQ:GOVX

$1.01 +0.01 (+1.07%)
As of 04:00 PM Eastern

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax Labs

Market Capitalization
$13.98 million
P/E Ratio
-0.18
Consensus Rating
Buy
Consensus Price Target
$12.90 (+1,177.2% Upside)
Volume
245,377 shares
Average Volume
590,731 shares
Reviva Pharmaceuticals stock logo

22. Reviva Pharmaceuticals NASDAQ:RVPH

$0.89 +0.01 (+1.48%)
As of 04:00 PM Eastern

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$41.60 million
P/E Ratio
-0.80
Consensus Rating
Buy
Consensus Price Target
$10.00 (+1,023.6% Upside)
Volume
252,433 shares
Average Volume
1.13 million shares
Cardiol Therapeutics stock logo

23. Cardiol Therapeutics NASDAQ:CRDL

$1.10 -0.05 (-4.35%)
As of 04:00 PM Eastern

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol Therapeutics

Market Capitalization
$95 million
P/E Ratio
-2.82
Consensus Rating
Buy
Consensus Price Target
$8.40 (+663.6% Upside)
Volume
157,297 shares
Average Volume
377,920 shares
Quince Therapeutics stock logo

24. Quince Therapeutics NASDAQ:QNCX

$1.10 -0.03 (-2.65%)
As of 04:00 PM Eastern

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$48.54 million
P/E Ratio
-0.89
Consensus Rating
Buy
Consensus Price Target
$8.00 (+627.3% Upside)
Volume
78,035 shares
Average Volume
248,775 shares
Full House Resorts stock logo

25. Full House Resorts NASDAQ:FLL

$3.23 -0.05 (-1.52%)
As of 04:00 PM Eastern

Full House Resorts, Inc owns, leases, operates, develops, manages, and invests in casinos, and related hospitality and entertainment facilities in the United States. More about Full House Resorts

Market Capitalization
$116.20 million
P/E Ratio
-2.74
Consensus Rating
Buy
Consensus Price Target
$6.33 (+96.1% Upside)
Volume
119,128 shares
Average Volume
134,697 shares